Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.35
0.924.50%
At Close: -
$21.40
0.050.23%
After Hours: 5:43 PM EDT
15 minutes delayed
Comments
Loading...
Catalyst Pharmaceuticals (CPRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Quotes, Forecast and News Summary
Catalyst Pharmaceuticals Stock (NASDAQ: CPRX) stock price, news, charts, stock research, profile.
| Open | $20.90 |
| Close | $21.35 |
| Volume / Avg. | 1.15M / 1.09M |
| Day Range | $20.78 - $21.36 |
| 52 Wk Range | 11.55 - 20.87 |
| Market Cap | $2.54B |
| P/E Ratio | 36.48 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 71 |
| Short Interest | 6.04% |
| Days to Cover | 6.49 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Catalyst Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercial...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Catalyst Pharmaceuticals (CPRX) stock?
You can purchase shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) through any online brokerage.
Who are Catalyst Pharmaceuticals (CPRX) competitors?
Other companies in Catalyst Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT), Protagonist Therapeutics (NASDAQ:PTGX) and Agios Pharmaceuticals (NASDAQ:AGIO).
What is the forecast, or price target, for Catalyst Pharmaceuticals (CPRX) stock?
Catalyst Pharmaceuticals has a consensus price target of $26.56.
What is the current price for Catalyst Pharmaceuticals (CPRX)?
The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $21.4 last updated September 19, 2024 at 5:43 PM EDT.
Does Catalyst Pharmaceuticals (CPRX) pay a dividend?
There are no upcoming dividends for Catalyst Pharmaceuticals.
When is Catalyst Pharmaceuticals (NASDAQ:CPRX) reporting earnings?
Catalyst Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Catalyst Pharmaceuticals (CPRX) going to split?
There is no upcoming split for Catalyst Pharmaceuticals.
What sector and industry does Catalyst Pharmaceuticals (CPRX) operate in?
Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.